These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 32542602)

  • 1. Preparation and Administration of Adeno-associated Virus Vectors for Corneal Gene Delivery.
    Song L; Bower JJ; Hirsch ML
    Methods Mol Biol; 2020; 2145():77-102. PubMed ID: 32542602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotype survey of AAV gene delivery via subconjunctival injection in mice.
    Song L; Llanga T; Conatser LM; Zaric V; Gilger BC; Hirsch ML
    Gene Ther; 2018 Sep; 25(6):402-414. PubMed ID: 30072815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AAV Gene Therapy for MPS1-associated Corneal Blindness.
    Vance M; Llanga T; Bennett W; Woodard K; Murlidharan G; Chungfat N; Asokan A; Gilger B; Kurtzberg J; Samulski RJ; Hirsch ML
    Sci Rep; 2016 Feb; 6():22131. PubMed ID: 26899286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct comparison of administration routes for AAV8-mediated ocular gene therapy.
    Igarashi T; Miyake K; Asakawa N; Miyake N; Shimada T; Takahashi H
    Curr Eye Res; 2013 May; 38(5):569-77. PubMed ID: 23489150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Developments in gene delivery vectors for ocular gene therapy].
    Khabou H; Dalkara D
    Med Sci (Paris); 2015 May; 31(5):529-37. PubMed ID: 26059304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraocular route of AAV2 vector administration defines humoral immune response and therapeutic potential.
    Li Q; Miller R; Han PY; Pang J; Dinculescu A; Chiodo V; Hauswirth WW
    Mol Vis; 2008 Sep; 14():1760-9. PubMed ID: 18836574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinal gene delivery by adeno-associated virus (AAV) vectors: Strategies and applications.
    Schön C; Biel M; Michalakis S
    Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):343-52. PubMed ID: 25615882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adeno-associated virus (AAV) vectors achieve prolonged transgene expression in mouse myocardium and arteries in vivo: a comparative study with adenovirus vectors.
    Vassalli G; Büeler H; Dudler J; von Segesser LK; Kappenberger L
    Int J Cardiol; 2003 Aug; 90(2-3):229-38. PubMed ID: 12957756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adeno-associated virus (AAV) vectors in cancer gene therapy.
    Santiago-Ortiz JL; Schaffer DV
    J Control Release; 2016 Oct; 240():287-301. PubMed ID: 26796040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SubILM Injection of AAV for Gene Delivery to the Retina.
    Gamlin PD; Alexander JJ; Boye SL; Witherspoon CD; Boye SE
    Methods Mol Biol; 2019; 1950():249-262. PubMed ID: 30783978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single stranded adeno-associated virus achieves efficient gene transfer to anterior segment in the mouse eye.
    Wang L; Xiao R; Andres-Mateos E; Vandenberghe LH
    PLoS One; 2017; 12(8):e0182473. PubMed ID: 28763501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivering Transgenic DNA Exceeding the Carrying Capacity of AAV Vectors.
    Hirsch ML; Wolf SJ; Samulski RJ
    Methods Mol Biol; 2016; 1382():21-39. PubMed ID: 26611576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modified infusion procedures affect recombinant adeno-associated virus vector type 2 transduction in the liver.
    Ohashi K; Nakai H; Couto LB; Kay MA
    Hum Gene Ther; 2005 Mar; 16(3):299-306. PubMed ID: 15812225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transduction Efficiency of Adeno-Associated Virus Serotypes After Local Injection in Mouse and Human Skeletal Muscle.
    Muraine L; Bensalah M; Dhiab J; Cordova G; Arandel L; Marhic A; Chapart M; Vasseur S; Benkhelifa-Ziyyat S; Bigot A; Butler-Browne G; Mouly V; Negroni E; Trollet C
    Hum Gene Ther; 2020 Feb; 31(3-4):233-240. PubMed ID: 31880951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subconjunctival Administration of Adeno-associated Virus Vectors in Small Animal Models.
    Bower JJ; Song Z; Song L
    J Vis Exp; 2022 Mar; (181):. PubMed ID: 35377357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Fixed-Depth Microneedle Enhances Reproducibility and Safety for Corneal Gene Therapy.
    Gilger BC; Crabtree E; Song L; Llanga T; Cullen M; Blanchard A; Salmon J; Patel S; Zarnitsyn V; Hirsch M
    Cornea; 2020 Mar; 39(3):362-369. PubMed ID: 31724981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Retinal Explant Culture for Ex Vivo Validation of AAV Gene Therapy.
    Orlans HO; Edwards TL; De Silva SR; Patrício MI; MacLaren RE
    Methods Mol Biol; 2018; 1715():289-303. PubMed ID: 29188522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-existing immunity to adeno-associated virus (AAV)2 limits transgene expression following intracerebral AAV2-based gene delivery in a 6-hydroxydopamine model of Parkinson's disease.
    Janelidze S; Nordström U; Kügler S; Brundin P
    J Gene Med; 2014; 16(9-10):300-8. PubMed ID: 25303717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutralizing Antibodies Against Adeno-Associated Virus (AAV): Measurement and Influence on Retinal Gene Delivery.
    Desrosiers M; Dalkara D
    Methods Mol Biol; 2018; 1715():225-238. PubMed ID: 29188517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotype-independent method of recombinant adeno-associated virus (AAV) vector production and purification.
    Miyake K; Miyake N; Yamazaki Y; Shimada T; Hirai Y
    J Nippon Med Sch; 2012; 79(6):394-402. PubMed ID: 23291836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.